Covaxin
The World Health Organization declared that it will make a decision on granting emergency use listing (EUL) to Bharat Biotech’s Covaxin next week.
The emergency use listing process will be conducted by WHO and the Technical Advisory Group of independent experts together to determine whether the COVID-19 vaccine by Bharat Biotech is quality-assured, safe, and effective.
The independent group of experts and WHO will come together next week to carry out the risk, benefit assessment and decide whether to grant the emergency use listing.
